Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cresco Labs (DE:6CQ)
FRANKFURT:6CQ
Cresco Labs (6CQ) Stock Price & Analysis
2 Followers
6CQ Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.89 - €2.60
Previous Close€1.79
Volume0.00
Average Volume (3M)1.51K
Market Cap
€818.39M
Enterprise Value€1.31B
Total Cash (Recent Filing)$103.43M
Total Debt (Recent Filing)$682.76M
Price to Earnings (P/E)-3.6
Beta1.32
Next Earnings
May 15, 2024EPS Estimate
-€0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.49
Shares Outstanding480,292,624
10 Day Avg. Volume487
30 Day Avg. Volume1,508
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)-14.10
Price to Sales (P/S)3.13
Price to Cash Flow (P/CF)-75.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.70
Enterprise Value/Gross Profit3.62
Enterprise Value/Ebitda-91.26
Forecast
1Y Price Target
€5.16Price Target Upside188.52% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Cresco Labs News
PremiumCompany Announcements
Cresco Labs Achieves Solid Profitability in 2023
PremiumCompany Announcements
Cresco Labs Announces Upcoming Earnings Release
Bulls Say, Bears Say
Bulls Say
Financial PerformanceCresco Labs Inc. reported results that significantly beat forecasts, highlighting a successful operational turnaround with profitable growth in core markets.
Market Expansion PotentialCresco Labs Inc. is poised for potential further growth as key medical markets are anticipated to transition to adult-use sales, offering a substantial opportunity for revenue expansion.
Operational EfficiencyThe Company's strategic investments in efficiency and cost optimizations have borne fruit, contributing to impressive earnings results and an 11% decrease in SG&A expenses.
Bears Say
Growth ExpectationsThe Company guided to a low-single-digit revenue decline in the upcoming quarter with softer organic growth expected in the following quarters.
Revenue OutlookManagement’s 2024 outlook is mixed with an anticipated low-single-digit revenue decline in the near term, suggesting a softer organic growth outlook.
Sales MomentumManagement expects revenues to be down by a mid-single-digit rate, with sales momentum appearing to drip lower, impacting 2024 forecasts.
---
Options Prices
Currently, No data available
---
Ownership Overview
58.72% Insiders
1.69% Mutual Funds
0.07% Other Institutional Investors
39.52% Public Companies and
Individual Investors
6CQ FAQ
What was Cresco Labs’s price range in the past 12 months?
Cresco Labs lowest stock price was €0.89 and its highest was €2.60 in the past 12 months.
What is Cresco Labs’s market cap?
Currently, no data Available
When is Cresco Labs’s upcoming earnings report date?
Cresco Labs’s upcoming earnings report date is May 15, 2024 which is in 18 days.
How were Cresco Labs’s earnings last quarter?
Cresco Labs released its earnings results on Mar 13, 2024. The company reported €0.009 earnings per share for the quarter, beating the consensus estimate of -€0.023 by €0.032.
Is Cresco Labs overvalued?
According to Wall Street analysts Cresco Labs’s price is currently Undervalued.
Does Cresco Labs pay dividends?
Cresco Labs does not currently pay dividends.
What is Cresco Labs’s EPS estimate?
Cresco Labs’s EPS estimate is -€0.02.
How many shares outstanding does Cresco Labs have?
Cresco Labs has 320,757,100 shares outstanding.
What happened to Cresco Labs’s price movement after its last earnings report?
Cresco Labs reported an EPS of €0.009 in its last earnings report, beating expectations of -€0.023. Following the earnings report the stock price went down -4.822%.
Which hedge fund is a major shareholder of Cresco Labs?
Currently, no hedge funds are holding shares in DE:6CQ
---
Cresco Labs Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€5.16 (188.52% Upside)
€5.16 (188.52% Upside)
Blogger Sentiment
Bullish
DE:6CQ Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $2.8M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
42.36%
12-Months-Change
Fundamentals
Return on Equity
-30.99%
Trailing 12-Months
Asset Growth
-14.22%
Trailing 12-Months
Company Description
Cresco Labs
Cresco Labs Inc is a Canada based company engaged in the production and sale of cannabis. The company distribute its products to dispensaries nationwide, including several dispensaries owned and operated by its team. Its product includes Reserve, Remedi, Mindy's. All the revenues of the company were generated in the United States. It has ownership interests in Illinois, Pennsylvania, Ohio, California, Maryland, and Arizona.
---
6CQ Company Deck
---
6CQ Earnings Call
Q4 2024
0:00 / 0:00
---
6CQ Stock 12 Months Forecast
Average Price Target
€5.16
▲(188.52% Upside)
Technical Analysis
Cresco Labs
―
Green Thumb Industries
―
Curaleaf Holdings
―
Trulieve Cannabis
―
Supernus Pharmaceuticals
―
Best Analysts Covering 6CQ
1 Year
1 Year Success Rate
9/23 ratings generated profit
1 Year Average Return
+14.51%
reiterated a buy rating 2 months ago
Copying Derek Dley's trades and holding each position for 1 Year would result in 39.13% of your transactions generating a profit, with an average return of +14.51% per trade.
---